NSHOHOCKEN, Pa.--(BUSINESS WIRE)--CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, announced today that CardioNet’s President and Chief Executive Officer, Joseph Capper, has adopted a Rule 10b5-1 trading plan to purchase shares of the Company’s common stock over time as part of his individual investment strategy. The trading plan is being established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934 and CardioNet’s policies regarding stock transactions.
